Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Apr 29;19(4):e0302544.
doi: 10.1371/journal.pone.0302544. eCollection 2024.

Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances

Affiliations
Comparative Study

Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances

John L Havlik et al. PLoS One. .

Abstract

The association of subjective mental health-related quality of life (MHRQOL) and treatment use among people experiencing common substance use disorders (SUDs) is not known. Furthermore, the association of a given substance's legal status with treatment use has not been studied. This work aims determine the association of MHRQOL with SUD treatment use, and how substance legal status modulates this relationship. Our analysis used nationally-representative data from the NESARC-III database of those experiencing past-year SUDs (n = 5,808) to compare rates of treatment use and its correlates among three groups: those with illicit substance use disorders (ISUDs); those with partially legal substance use disorders, i.e., cannabis use disorder (CUD); and those with fully legal substance use disorders, i.e., alcohol use disorder (AUD). Survey-weighted multiple regression analysis was used to assess the association of MHRQOL with likelihood of treatment use among these three groups, both unadjusted and adjusted for sociodemographic, behavioral, and diagnostic factors. Adults with past-year ISUDs were significantly more likely to use treatment than those with CUD and AUD. Among those with ISUDs, MHRQOL had no significant association with likelihood of treatment use. Those with past-year CUD saw significant negative association of MHRQOL with treatment use in unadjusted analysis, but not after controlling for diagnostic and other behavioral health factors. Those with past-year AUD had significant negative association of MHRQOL with treatment use in both unadjusted and adjusted analysis. If legalization and decriminalization continue, there may be a greater need for effective public education and harm reduction services to address this changing SUD landscape.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Hammond D, Goodman S, Wadsworth E, Rynard V, Boudreau C, Hall W. Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study. International Journal of Drug Policy. 2020;77: 102698. doi: 10.1016/j.drugpo.2020.102698 - DOI - PubMed
    1. Carhart-Harris RL, Goodwin GM. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology 2017 42:11. 2017;42: 2105–2113. doi: 10.1038/npp.2017.84 - DOI - PMC - PubMed
    1. Virani HN, Haines-Saah RJ. Drug Decriminalization: A Matter of Justice and Equity, Not Just Health. Am J Prev Med. 2020;58: 161–164. doi: 10.1016/j.amepre.2019.08.012 - DOI - PubMed
    1. Rouhani S, McGinty EE, Weicker NP, White RH, LaSalle L, Barry CL, et al.. Racial resentment and support for decriminalization of drug possession in the United States. Prev Med (Baltim). 2022;163: 107189. doi: 10.1016/j.ypmed.2022.107189 - DOI - PubMed
    1. Paquette C, Syvertsen J, Pollini R. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57: 104–110. doi: 10.1016/j.drugpo.2018.04.004 - DOI - PMC - PubMed

Publication types